Internal Medicine, Hematology & Oncology · Henderson, NV
NPI
1144220781
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2460 W Horizon Ridge Pkwy
Henderson, NV, 89052
Phone (702) 822-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
166,043 services
Medicare patients, 2024
407
Average age 74
Drug cost, 2024
$2.2M
1,284 prescriptions
Company payments, 2025
$5,625
From 40 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramalingam Ratnasabapathy was code Q5110 (injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram), 21,120 times for 12 patients. In total Ramalingam Ratnasabapathy billed 166,043 services in 163 codes, and Medicare paid $2.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 21,120 | 12 | $0.22 | $4,699 |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 20,910 | 26 | $0.28 | $5,865 |
| Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | Office | 18,060 | 11 | $0.26 | $4,649 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 9,000 | 12 | $0.11 | $1,033 |
| J0897 Injection, denosumab, 1 mg | Office | 5,340 | 26 | $20.51 | $110K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,377 | 62 | $0.09 | $213 |
| 85025 Blood Count | Office | 1,271 | 256 | $7.61 | $9,672 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,150 | 18 | $0.72 | $826 |
| 80053 Clinical Chemistry | Office | 1,128 | 249 | $10.34 | $12K |
| 99214 Office E&M - Established | Office | 1,122 | 234 | $102.20 | $115K |
| 36415 Venipuncture Blood Collection | Office | 1,059 | 252 | $8.64 | $9,154 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 772 | 211 | $13.01 | $10K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 760 | 13 | $0.25 | $187 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 560 | 12 | $5.84 | $3,268 |
| 96375 Injection Administration | Office | 389 | 68 | $12.54 | $4,878 |
By year: 2022 $1.4M for 141,467 services; 2023 $1.8M for 140,957 services; 2024 $2.0M for 166,043 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,271 | 256 | $7.61 | $9,672 |
| 80053 Clinical Chemistry | 1,128 | 249 | $10.34 | $12K |
| 36415 Venipuncture Blood Collection | 1,059 | 252 | $8.64 | $9,154 |
| 82784 Immunoassay | 120 | 25 | $9.11 | $1,094 |
| 83615 Clinical Chemistry | 100 | 58 | $5.92 | $592 |
| 82728 Clinical Chemistry | 98 | 62 | $13.36 | $1,309 |
| 83550 Clinical Chemistry | 97 | 61 | $8.57 | $831 |
| 83540 Clinical Chemistry | 97 | 61 | $6.34 | $615 |
| 85610 Clinical Chemistry | 89 | 21 | $4.20 | $374 |
| 84481 Clinical Chemistry | 89 | 40 | $16.42 | $1,462 |
Medicare prescription drug claims, 2024
In 2024, the drug Ramalingam Ratnasabapathy prescribed most often to Medicare patients was Eliquis (Apixaban), with 67 prescriptions and refills. In total Ramalingam Ratnasabapathy wrote 1,284 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 67 | 125 | 18 | $71K |
| Letrozole Generic | 55 | 148 | 14 | $1,149 |
| Levofloxacin Generic | 52 | 52 | 24 | $400 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 51 | 51 | 11 | $1,655 |
| Gabapentin Generic | 45 | 63 | 14 | $958 |
| Ondansetron Hcl Generic | 44 | 44 | 22 | $421 |
| Hydroxyurea Generic | 39 | 70 | Under 11 | $657 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 36 | 36 | 12 | $1,335 |
| Prednisone Generic | 32 | 38 | Under 11 | $198 |
| Atorvastatin Calcium Generic | 29 | 78 | 12 | $436 |
| Levothyroxine Sodium Generic | 27 | 58 | Under 11 | $261 |
| Olanzapine Generic | 25 | 33 | Under 11 | $302 |
| Furosemide Generic | 25 | 37 | 13 | $67.14 |
| Alendronate Sodium Generic | 25 | 29 | Under 11 | $93.87 |
| Hydrocortisone Generic | 24 | 28 | Under 11 | $789 |
Brand drugs: 247 claims; generic drugs: 1,037 claims; opioid claims: 126.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramalingam Ratnasabapathy $5,625 ($5,625 in general payments such as food, travel and fees) from 40 companies. The largest payer was Daiichi Sankyo Inc. with $1,164.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 59 | $1,164 |
| Novartis Pharmaceuticals Corporation NVS | 32 | $576 |
| Azurity Pharmaceuticals, Inc. | 6 | $401 |
| Gilead Sciences, Inc. GILD | 9 | $276 |
| Exelixis Inc. EXEL | 5 | $250 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $237 |
| Tempus AI, Inc TEM | 10 | $217 |
| Sobi, Inc SOBI.ST | 16 | $205 |
| Incyte Corporation INCY | 6 | $193 |
| Janssen Biotech, Inc. JNJ | 5 | $185 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.